Patents Assigned to PrognomIQ, Inc.
  • Lung biomarkers and methods of use thereof
    Patent number: 11664092
    Abstract: Disclosed herein are biomarkers associated with a disease state such as lung cancer, and methods of discovering or using biomarkers. Also disclosed herein are classifiers built on biomarkers and methods of detecting the disease state in samples from subjects. The method may include obtaining a data set that includes protein information from a biofluid sample, and may involve using a classifier to identify the sample as indicative of a healthy state, a disease state, or a comorbidity.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: May 30, 2023
    Assignee: PrognomIQ, Inc.
    Inventors: John E. Blume, William C. Manning, Gregory Troiano, Asim Siddiqui, Philip Ma, Omid C. Farokhzad